Nalaganje...

Long-Term Disease Control of a Pancreatic Neuroendocrine Tumor with Lanreotide Autogel(®): A Case Report

The CLARINET study (ClinicalTrials.gov: NCT00353496) showed that somatostatin analogs are able to stabilize tumor growth in patients with intestinal and pancreatic neuroendocrine tumors (NETs). Here, we present a case of NET originating from the pancreatic tail that was treated with lanreotide Autog...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Case Rep Oncol
Main Authors: Lybaert, Willem, Van Hul, Erik, Woestenborghs, Heidi
Format: Artigo
Jezik:Inglês
Izdano: S. Karger AG 2014
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4224256/
https://ncbi.nlm.nih.gov/pubmed/25408662
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000368207
Oznake: Označite
Brez oznak, prvi označite!